<!--[if !IE]> This has been served from cache <![endif]-->
<!--[if !IE]> Request served from apache server: S264630NJ2XSF20 <![endif]-->
<!--[if !IE]> Cached on Tue, 23 Aug 2016 13:50:27 GMT and will expire on Tue, 23 Aug 2016 14:05:27 GMT <![endif]-->
<!--[if !IE]> token: f20f91c3-7c85-453d-b76a-89ed58e0e217 <![endif]-->
<!--[if !IE]> CSTAT-UUID: 4bc8059a-7ca0-40fe-86e0-993215422de5 <![endif]-->
<!--[if !IE]> App Server /S264630NJ2XSF52/ <![endif]-->

<!doctype html><html><head>
<title>
            Pfizer walks away from $118 billion AstraZeneca takeover fight
| Reuters</title>
    <meta http-equiv="X-UA-Compatible" content="IE=edge"><meta charset="utf-8"><meta http-equiv="x-dns-prefetch-control" content="on"><link rel="dns-prefetch" href="//s1.reutersmedia.net"/><link rel="dns-prefetch" href="//s2.reutersmedia.net"/><link rel="dns-prefetch" href="//s3.reutersmedia.net"/><link rel="dns-prefetch" href="//s4.reutersmedia.net"/><link rel="dns-prefetch" href="//static.reuters.com"/><meta name="robots" content="INDEX, FOLLOW">

<meta name="google-site-verification" content="SVDMcE-27ZUUuh-EcZzejAJ0YIFjxD9H_nwAX6YVTw4" /><meta name="msvalidate.01" content="2055F771212E9574BFD5AF29D47FBA04" /><script type="text/javascript" >

// Rubicon Initialize
(function() {
    var account_id = 11384;
    var rct = document.createElement('script');
        rct.type = 'text/javascript';
        rct.async = true;
        rct.src = (document.location.protocol === 'https:' ? 'https:' : 'http:') + '//ads.rubiconproject.com/header/' + account_id + '.js';
    var node = document.getElementsByTagName('script')[0];
        node.parentNode.appendChild(rct);
})();

</script><script type="text/javascript" src="//reuters-d.openx.net/w/1.0/jstag?nc=4735792-reuters"></script><div class="linebreak"></div>
	<style>
@font-face { font-family: 'knowledge-reg'; src: url('/resources_v2/fonts/Knowledge-Regular.woff') format('woff'); font-weight: normal; font-style: normal; }
@font-face { font-family: 'knowledge-light'; src: url('/resources_v2/fonts/Knowledge-Light.woff') format('woff'); font-weight: normal; font-style: normal; }
@font-face { font-family: 'knowledge-medium'; src: url('/resources_v2/fonts/Knowledge-Medium.woff') format('woff'); font-weight: normal; font-style: normal; }
</style>

<script type="text/javascript" src="http://www.reuters.com/reuters_bootstrap.js"></script><script type="text/javascript" src="http://www.reuters.com/reuters_gpt_bootstrap.js"></script>
<script type="text/javascript">var abp;</script><script type="text/javascript" src="http://s4.reutersmedia.net/resources_v2/js/px.js?ch=1"></script><script type="text/javascript" src="http://s4.reutersmedia.net/resources_v2/js/px.js?ch=2"></script>
<script type="text/javascript">
var parallelMediaHosts = new Array();
parallelMediaHosts.push("s1.reutersmedia.net");parallelMediaHosts.push("s2.reutersmedia.net");parallelMediaHosts.push("s3.reutersmedia.net");parallelMediaHosts.push("s4.reutersmedia.net");</script>

<meta name="DCSext.ContentChannel" content="innovationNews" />
<meta name="DCSext.ChannelList" content="topNews;newsOne;businessNews;innovationNews;globalMarketsNews;innovationNewsHealthcare;americasDealsNews;americasPrivateEquityNews;euDealsNews;euPrivateEquityNews;FixedIncome;TechLife;attInternational;ford;Honda;SustainabilitySocial;Genentech;creditMarkets;everything;treasuryMarkets;Continental;Deals;MercedesBenz;Shell;Verizon;Amtrak;Amtrak2;Topnews1;yahoo2Dub;yahoo3;Sprintboard;echoActivityStream;ANZ;HSBC_US;everythingButHugin;msnMoneyFeed;SprintNow;OutloudFeed;JPMorgan;CFA;trending-hp;samsung;newsproHome;audib2b;cfaglobal;merrilledge;aa48hours;ernstyoung;shipping;citianniversary;PrudentialInvestments;MLGZero;fedex_neg;investingsimplified;MLedge;BNY;Bosneg;Intel;BNYForesight;PFG" />
<meta name="DCSext.ContentHeadline" content="Pfizer+walks+away+from+%24118+billion+AstraZeneca+takeover+fight" />
<meta name="DCSext.PageNumber" content="1" />
<meta name="DCSext.PageTotal" content="2" />
<meta name="DCSext.contentversion" content="original" />
<meta name="DCSext.rAuthor" content="Ben Hirschler and Bill Berkrot">
<meta name="DCSext.Comments" content="1">
<meta name="WT.z_inlinetype" content="false" />
<meta name="WT.z_navid" content="nav-Text-innovationNews" />

<link rel="canonical" href="http://www.reuters.com/article/us-astrazeneca-pfizer-idUSBREA3R0H520140526" />
<link rel="alternate" href="http://uk.reuters.com/article/us-astrazeneca-pfizer-idUKBREA3R0H520140526" hreflang="en-gb" />
<link rel="alternate" href="http://in.reuters.com/article/us-astrazeneca-pfizer-idINBREA3R0H520140526" hreflang="en-in" />
<link rel="alternate" href="http://www.reuters.com/article/us-astrazeneca-pfizer-idUSBREA3R0H520140526" hreflang="en" /><link rel="alternate" media="only screen and (max-width: 640px)" href="http://mobile.reuters.com/article/idUSBREA3R0H520140526" />
<meta name="description" content="Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker.">
<meta name="Author" content="Ben Hirschler and Bill Berkrot">
<link rel="image_src" href="http://s1.reutersmedia.net/resources/r/?m=02&d=20140526&t=2&i=900106729&w=&fh=545px&fw=&ll=&pl=&sq=&r=CBREA460M4L00" />
<meta name="keywords" content="Andrew Kelly,US,ASTRAZENECA,PFIZER,Generic and Specialty Pharmaceuticals (TRBC),United Kingdom,Company News,Labour / Personnel,Healthcare (TRBC),Government Borrowing Requirement,Chemicals (Legacy),Deals,Pharmaceuticals and Medical Research (TRBC),Regulation,Biotechnology and Medical Research (TRBC),United States,Sweden,Europe,Nordic States,Government / Politics,Switzerland,Mergers / Acquisitions / Takeovers,Major News,General News,Corporate Events,Pharmaceuticals (TRBC),Western Europe,Central / Eastern Europe,Americas" />
<meta name="news_keywords" content="Andrew Kelly;US;ASTRAZENECA;PFIZER;Generic and Specialty Pharmaceuticals (TRBC);United Kingdom;Company News;Labour / Personnel;Healthcare (TRBC);Government Borrowing Requirement;Chemicals (Legacy);Deals;Pharmaceuticals and Medical Research (TRBC);Regulation;Biotechnology and Medical Research (TRBC);United States;Sweden;Europe;Nordic States;Government / Politics;Switzerland;Mergers / Acquisitions / Takeovers;Major News;General News;Corporate Events;Pharmaceuticals (TRBC);Western Europe;Central / Eastern Europe;Americas" />
<meta name="REVISION_DATE" content="Mon May 26 15:55:17 UTC 2014">

<meta name="sailthru.author" content="Ben Hirschler and Bill Berkrot" />
<meta name="sailthru.date" content="2014-05-26T15:55:17+0000" />
<meta name="sailthru.title" content="Pfizer walks away from $118 billion AstraZeneca takeover fight" />

<meta property="og:locale" content="en_US"/>
<meta property="og:site_name" content="Reuters" />
<meta name="site edition" content="Reuters" />
<meta property="article:publisher" content="https://www.facebook.com/Reuters" />
<meta property="og:title" content="Pfizer walks away from $118 billion AstraZeneca takeover fight" />
<meta property="og:url" content="http://www.reuters.com/article/us-astrazeneca-pfizer-idUSBREA3R0H520140526" />
<meta property="og:type" content="article" />
<meta property="og:description" content="Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker.">
<meta property="og:image" content="http://s1.reutersmedia.net/resources/r/?m=02&d=20140526&t=2&i=900106729&w=&fh=545px&fw=&ll=&pl=&sq=&r=CBREA460M4L00" />
<meta property="og:article:published_time" content="2014-05-26T15:55:17+0000" />
<meta property="og:article:modified_time" content="2014-05-26T15:55:17+0000" /> 
<meta property="og:article:section" content="Business" /> 
<meta property="og:article:author" content="Ben Hirschler and Bill Berkrot" />
<meta property="og:article:tag" content="Andrew Kelly,US,ASTRAZENECA,PFIZER,Generic and Specialty Pharmaceuticals (TRBC),United Kingdom,Company News,Labour / Personnel,Healthcare (TRBC),Government Borrowing Requirement,Chemicals (Legacy),Deals,Pharmaceuticals and Medical Research (TRBC),Regulation,Biotechnology and Medical Research (TRBC),United States,Sweden,Europe,Nordic States,Government / Politics,Switzerland,Mergers / Acquisitions / Takeovers,Major News,General News,Corporate Events,Pharmaceuticals (TRBC),Western Europe,Central / Eastern Europe,Americas" />

<meta name="twitter:site" content="@Reuters" />
<meta name="twitter:creator" content="@Reuters" />
<link rel="publisher" href="https://plus.google.com/+Reuters"/>
    <meta name="twitter:card" content="summary_large_image"> 
    <meta name="twitter:title" content="Pfizer walks away from $118 billion AstraZeneca takeover fight" />
<meta name="twitter:description" content="Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker.">
<meta name="twitter:image:src" content="http://s1.reutersmedia.net/resources/r/?m=02&d=20140526&t=2&i=900106729&w=&fh=545px&fw=&ll=&pl=&sq=&r=CBREA460M4L00">
<meta name="twitter:image" content="http://s1.reutersmedia.net/resources/r/?m=02&d=20140526&t=2&i=900106729&w=&fh=545px&fw=&ll=&pl=&sq=&r=CBREA460M4L00" />


<script type="application/ld+json">
    {
        "@context": "http://schema.org",
        "article": {
            "@type": "NewsArticle",
            "headline": "Pfizer walks away from $118 billion AstraZeneca takeover fight",
            "url": "http://www.reuters.com/article/us-astrazeneca-pfizer-idUSBREA3R0H520140526",
            "thumbnailUrl": "http://s1.reutersmedia.net/resources/r/?m=02&d=20140526&t=2&i=900106729&w=&fh=545px&fw=&ll=&pl=&sq=&r=CBREA460M4L00",
            "dateCreated": "2014-05-26T15:55:17+0000",
            "dateModified": "2014-05-26T15:55:17+0000",
            "datePublished": "2014-05-26T15:55:17+0000",
            "description": "Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker.",
            "publisher": "Reuters",
            "articleSection": "Business",
            "creator": ["Ben Hirschler and Bill Berkrot"],
            "keywords": ["Andrew Kelly","US","ASTRAZENECA","PFIZER","Generic and Specialty Pharmaceuticals (TRBC)","United Kingdom","Company News","Labour / Personnel","Healthcare (TRBC)","Government Borrowing Requirement","Chemicals (Legacy)","Deals","Pharmaceuticals and Medical Research (TRBC)","Regulation","Biotechnology and Medical Research (TRBC)","United States","Sweden","Europe","Nordic States","Government / Politics","Switzerland","Mergers / Acquisitions / Takeovers","Major News","General News","Corporate Events","Pharmaceuticals (TRBC)","Western Europe","Central / Eastern Europe","Americas","Article","Deals"],
            "about":"Article"
        }
    }
</script>
<meta name="DCSext.rChannel" content="Article - News"> 

<meta name="DCSext.ContentChannel"  content="Homepage">
<meta name="DCSext.ContentType"  content="Article">
<meta name="DCSext.DartZone" content="us.reuters/business/deals/article" />
<meta name="WT.cg_n" content="Business">
<meta name="WT.cg_s" content="Deals">
<link rel="shortcut icon" type="image/x-icon" href="http://s3.reutersmedia.net/resources_v2/images/favicon/favicon.ico" />
<link rel="icon" type="image/png" href="http://s3.reutersmedia.net/resources_v2/images/favicon/favicon-16x16.png" sizes="16x16" />
<link rel="icon" type="image/png" href="http://s1.reutersmedia.net/resources_v2/images/favicon/favicon-32x32.png" sizes="32x32" />
<link rel="icon" type="image/png" href="http://s3.reutersmedia.net/resources_v2/images/favicon/favicon-96x96.png" sizes="96x96" />
<link rel="stylesheet" type="text/css" href="http://s2.reutersmedia.net/resources_v2/css/core.css" />
<link rel="stylesheet" type="text/css" href="http://s4.reutersmedia.net/resources_v2/css/core-modules.css" />
    <link rel="stylesheet" type="text/css" href="http://s2.reutersmedia.net/resources_v2/css/core-article.css" />
    <script src="http://s3.reutersmedia.net/resources_v2/js/libraries/jquery-2.2.4.min.js" type="text/javascript"></script>

<script src="http://s2.reutersmedia.net/resources_v2/js/libraries/cookie.js" type="text/javascript"></script>
<script src="http://s2.reutersmedia.net/resources_v2/js/core.js" type="text/javascript"></script>
<script src="http://s4.reutersmedia.net/resources_v2/js/libraries/slideshow.js" type="text/javascript"></script>
<script src="http://s2.reutersmedia.net/resources_v2/js/search.js" type="text/javascript"></script>
<script type="text/javascript" src="http://s4.reutersmedia.net/resources_v2/js/core-most-popular.js"></script>
<script type="text/javascript">
  window._taboola = window._taboola || [];
  _taboola.push({article:'auto'});
  !function (e, f, u) {
    e.async = 1;
    e.src = u;
    f.parentNode.insertBefore(e, f);
  }(document.createElement('script'),
  document.getElementsByTagName('script')[0],
  '//cdn.taboola.com/libtrc/reuters-network/loader.js');
</script>
<script type='text/javascript'>
        var _sf_async_config = _sf_async_config || {};
        _sf_async_config.uid = 52639; 
        _sf_async_config.domain = 'reuters.com';  
        _sf_async_config.topStorageDomain = 'reuters.com'; 
        _sf_async_config.path = document.querySelector("link[rel='canonical']").getAttribute("href").replace('http://www.', ''); 
        _sf_async_config.flickerControl = false;
        var _sf_startpt = (new Date()).getTime();
    </script><script async src='//static.chartbeat.com/js/chartbeat_mab.js'></script></head>
<body class="BETAUS article">
<div class="inter_bg"></div><div class="close_button" onClick="javascript:$('.inter_bg').hide();$('#div_gpt_intro').hide();$('#div_gpt_intro2').hide();"></div><div id="div_gpt_intro2" style="display:none;"></div>
<script>function inter_pop(){$(".inter_bg, .close_button").show(),$("#div_gpt_intro2").append($(".close_button"))}function close_pop(){$(".inter_bg, .close_button, #div_gpt_intro2").fadeOut()}function createCookie(e,t,o){if(o){var n=new Date;n.setTime(n.getTime()+24*o*60*60*1e3);var r="; expires="+n.toGMTString()}else var r="";document.cookie=e+"="+t+r+"; path=/"}function readCookie(e){for(var t=e+"=",o=document.cookie.split(";"),n=0;n<o.length;n++){for(var r=o[n];" "==r.charAt(0);)r=r.substring(1,r.length);if(0==r.indexOf(t))return r.substring(t.length,r.length)}return null}function eraseCookie(e){createCookie(e,"",-1)}TR3.extractDartZone().indexOf("jp.reuters")>-1&&$(".close_button").html("閉じる");var x=readCookie("r_inter");"true"==x?TR3.log("inter cookie:true"):displayAd("div_gpt_intro2",TR3.extractDartZone(),[640,480],"type=intro_gpt;"+adParams2);</script><div id="div_gpt_intro" style="display:none;"></div>
<script>function close_pop2(){$("#div_gpt_intro").fadeOut()}function createCookie(e,t,o){if(o){var r=new Date;r.setTime(r.getTime()+24*o*60*60*1e3);var i="; expires="+r.toGMTString()}else var i="";document.cookie=e+"="+t+i+"; path=/"}function readCookie(e){for(var t=e+"=",o=document.cookie.split(";"),r=0;r<o.length;r++){for(var i=o[r];" "==i.charAt(0);)i=i.substring(1,i.length);if(0==i.indexOf(t))return i.substring(t.length,i.length)}return null}function eraseCookie(e){createCookie(e,"",-1)}var x=readCookie("r_inter");"true"==x?TR3.log("inter cookie:true"):(setTimeout(function(){close_pop2()},15e3),displayAd("div_gpt_intro",TR3.extractDartZone(),"","type=intro_gpt;"+adParams2));</script>



<!-- Google Tag Manager -->
    <noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-W9SLGS"
    height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <script>if (location.href.indexOf('/commentsChild?') == -1){ (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})
    (window,document,'script','dataLayer','GTM-W9SLGS'); }</script>
    <!-- End Google Tag Manager -->

    <section id="breakingNewsContainer" class="hidden"><div id="breakingNews" class="group wrap"><div class="breaking-content"><div class="breaking-news-type"></div><div class="breaking-news-content"></div></div><div class="close-btn">X</div></div></section>

    <header id="headerMain">
        <div class="container group">
            <div class="edition-container group">
                <div class="edition-label">Edition:</div>
                <div class="edition-selector">
                    <div class="edition">United States</div>
                    <div class="edition-arrow"></div>
                </div>
            </div>
            <div class="reuters-nav-main">
                <h2 class="reuters-logo">
                    <a href="/" title="Reuters"></a>
                </h2>
            </div>
            <div id="utilities" class="utilities"></div>
        </div>
    </header>
    <nav id="headerNav">
        <div class="container group">
            <div class="header-mini-logo">
                    <a href="/" title="Reuters"></a>
            </div>
            <ul class="horizontal-list nav-list">
                <li class="nav-item home-tab active-icon
                                                no-subnav" id="nav-item-1">
                                            <a href="/home" class="nav-link-sec">
                                                <div class="home-icon"></div>
                                                <span class="text"></span>
                                            </a>
                                        </li>
                <li class="nav-item" id="nav-item-2">
                                       <a href="/finance" class="nav-link-sec">Business</a>
                                <div class="subnav" id="subnav-2">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="/finance" class="nav-link-subsec">Business Home</a></li>
                                        <li><a href="/legal" class="nav-link-subsec">Legal</a></li>
                                        <li><a href="/finance/deals" class="nav-link-subsec">Deals</a></li>
                                        <li><a href="/subjects/aerospace-and-defense" class="nav-link-subsec">Aerospace & Defense</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="/subjects/banks" class="nav-link-subsec">Finance</a></li>
                                        <li><a href="/subjects/autos" class="nav-link-subsec">Autos</a></li>
                                        <li><a href="/finance/summits" class="nav-link-subsec">Reuters Summits</a></li>
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item" id="nav-item-3">
                                       <a href="/finance/markets" class="nav-link-sec">Markets</a>
                                <div class="subnav" id="subnav-3">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="/finance/markets" class="nav-link-subsec">Markets Home</a></li>
                                        <li><a href="/finance/markets/us" class="nav-link-subsec">U.S. Markets</a></li>
                                        <li><a href="/finance/markets/europe" class="nav-link-subsec">European Markets</a></li>
                                        <li><a href="/finance/markets/asia" class="nav-link-subsec">Asian Markets</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="/finance/global-market-data" class="nav-link-subsec">Global Market Data</a></li>
                                        <li><a href="/finance/markets/indices" class="nav-link-subsec">Indices</a></li>
                                        <li><a href="/finance/stocks" class="nav-link-subsec">Stocks</a></li>
                                        <li><a href="/finance/bonds" class="nav-link-subsec">Bonds</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="/finance/currencies" class="nav-link-subsec">Currencies</a></li>
                                        <li><a href="/finance/commodities" class="nav-link-subsec">Comm & Energy</a></li>
                                        <li><a href="/finance/futures" class="nav-link-subsec">Futures</a></li>
                                        <li><a href="/finance/funds" class="nav-link-subsec">Funds</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="/finance/EarningsUS" class="nav-link-subsec">Earnings</a></li>
                                        <li><a href="/finance/markets/dividends" class="nav-link-subsec">Dividends</a></li>
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item" id="nav-item-4">
                                       <a href="/news/world" class="nav-link-sec">World</a>
                                <div class="subnav" id="subnav-4">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="/news/world" class="nav-link-subsec">World Home</a></li>
                                        <li><a href="/news/us" class="nav-link-subsec">U.S.</a></li>
                                        <li><a href="/subjects/specialReports" class="nav-link-subsec">Special Reports</a></li>
                                        <li><a href="http://www.reuters.com/investigates/" class="nav-link-subsec">Reuters Investigates</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="/subjects/euro-zone" class="nav-link-subsec">Euro Zone</a></li>
                                        <li><a href="/subjects/middle-east" class="nav-link-subsec">Middle East</a></li>
                                        <li><a href="/places/china" class="nav-link-subsec">China</a></li>
                                        <li><a href="/places/japan" class="nav-link-subsec">Japan</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="/places/mexico" class="nav-link-subsec">Mexico</a></li>
                                        <li><a href="/places/brazil" class="nav-link-subsec">Brazil</a></li>
                                        <li><a href="/places/africa" class="nav-link-subsec">Africa</a></li>
                                        <li><a href="/places/russia" class="nav-link-subsec">Russia</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="/places/india" class="nav-link-subsec">India</a></li>
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item" id="nav-item-5">
                                       <a href="/politics" class="nav-link-sec">Politics</a>
                                <div class="subnav" id="subnav-5">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="/politics" class="nav-link-subsec">Politics Home</a></li>
                                        <li><a href="/politics/election2016" class="nav-link-subsec">Election 2016</a></li>
                                        <li><a href="http://polling.reuters.com" class="nav-link-subsec">Polling Explorer</a></li>
                                        <li><a href="http://live.reuters.com/Event/Election_2016" class="nav-link-subsec">Just In</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="http://www.reuters.com/election2016/the-undecided/" class="nav-link-subsec">What Voters Want</a></li>
                                        <li><a href="/subjects/supreme-court" class="nav-link-subsec">Supreme Court</a></li>
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item" id="nav-item-6">
                                       <a href="/news/technology" class="nav-link-sec">Tech</a>
                                <div class="subnav" id="subnav-6">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="/news/technology" class="nav-link-subsec">Technology Home</a></li>
                                        <li><a href="/news/science" class="nav-link-subsec">Science</a></li>
                                        <li><a href="/bizfinance/technology/Top100Innovators" class="nav-link-subsec">Top 100 Global Innovators</a></li>
                                        <li><a href="/news/environment" class="nav-link-subsec">Environment</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="/innovation" class="nav-link-subsec">Innovation</a></li>
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item" id="nav-item-7">
                                       <a href="/commentary/" class="nav-link-sec">Commentary</a>
                                <div class="subnav" id="subnav-7">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="/commentary/" class="nav-link-subsec">Commentary Home </a></li>
                                        <li><a href="/tools/podcasts/" class="nav-link-subsec">Podcasts</a></li>
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item" id="nav-item-8">
                                       <a href="http://blogs.reuters.com/breakingviews/" class="nav-link-sec">Breakingviews</a>
                                <div class="subnav" id="subnav-8">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="http://blogs.reuters.com/breakingviews/" class="nav-link-subsec">Breakingviews Home</a></li>
                                        <li><a href="/video/breakingviews" class="nav-link-subsec">Breakingviews Video</a></li>
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item" id="nav-item-9">
                                       <a href="/finance/personal-finance" class="nav-link-sec">Money</a>
                                <div class="subnav" id="subnav-9">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="/finance/personal-finance" class="nav-link-subsec">Money Home</a></li>
                                        <li><a href="/finance/personal-finance/retirement" class="nav-link-subsec">Retirement</a></li>
                                        <li><a href="/subjects/us-lipper-awards" class="nav-link-subsec">Lipper Awards</a></li>
                                        <li><a href="https://commerce.us.reuters.com/purchase/default.do" class="nav-link-subsec">Analyst Research</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="http://stockscreener.us.reuters.com/Stock/US/Index?quickscreen=gaarp" class="nav-link-subsec">Stock Screener</a></li>
                                        <li><a href="http://funds.us.reuters.com/US/screener/screener.asp" class="nav-link-subsec">Fund Screener</a></li>
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item" id="nav-item-10">
                                       <a href="/news/lifestyle" class="nav-link-sec">Life</a>
                                <div class="subnav" id="subnav-10">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="/news/health" class="nav-link-subsec">Health</a></li>
                                        <li><a href="/news/sports" class="nav-link-subsec">Sports</a></li>
                                        <li><a href="/news/entertainment/arts" class="nav-link-subsec">Arts</a></li>
                                        <li><a href="/news/entertainment" class="nav-link-subsec">Entertainment</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        <li><a href="/news/oddlyEnough" class="nav-link-subsec">Oddly Enough</a></li>
                                        <li><a href="http://blogs.reuters.com/faithworld" class="nav-link-subsec">Faithworld</a></li>
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item pictures-tab active-icon active-text
                                               " id="nav-item-11">
                                            <a href="/news/pictures" class="nav-link-sec">
                                                <div class="pictures-icon"></div>
                                                <span class="text">Pictures</span>
                                            </a>
                                        <div class="subnav" id="subnav-11">
                            <div class="subnav-inset">
                                <ul class="subnav-list">
                                    <li><a href="/news/pictures" class="nav-link-subsec">Pictures Home</a></li>
                                        <li><a href="http://widerimage.reuters.com" class="nav-link-subsec">The Wider Image</a></li>
                                        <li><a href="http://widerimage.reuters.com/photographer" class="nav-link-subsec">Photographers</a></li>
                                        <li><a href="/focus-360/" class="nav-link-subsec">Focus 360</a></li>
                                        </ul>
                                            <ul class="subnav-list">
                                        </ul>
                            </div>
                        </div>
                    </li>
                <li class="nav-item video-tab active-icon active-text
                                                no-subnav" id="nav-item-12">
                                            <a href="/video" class="nav-link-sec">
                                                <div class="video-icon"></div>
                                                <span class="text">Video</span>
                                            </a>
                                        </li>
                <li class="nav-item search-tab active-icon no-subnav"><div class="search-icon"></div></li>
            </ul>
            <div id="searchBar">
                <form id="searchForm" class="search-form" name="searchbox" method="get" action="/search/news" autocomplete="off">
                    <input id="searchfield" class="search-field" name="blob" type="text" value="" onfocus="this.value = this.value;"  size="30" maxlength="128">
                    <span class="search-line"></span>
                    <input type="submit" id="search-submit-button" class="search-submit-button" value="" onmousedown="if(document.forms['searchbox'].blob.value == 'Search Reuters') { document.forms['searchbox'].blob.value = ''; }">
                    <div class="search-close-button"></div>
                </form>
            </div>
            <div class="article-mini-nav">
    <div class="mini-nav-info">
        <span class="mini-nav-headline">
            Pfizer walks away from $118 billion AstraZeneca takeover fight</span></div>
    <div class="mini-nav-share">
        <div class="core-share nav-share" 
            data-share-short-url="http://reut.rs/1jmPMjr"
            data-share-url="http://www.reuters.com/article/us-astrazeneca-pfizer-idUSBREA3R0H520140526"
            data-share-title="Pfizer walks away from $118 billion AstraZeneca takeover fight"
            data-share-desc="Pfizer walks away from $118 billion AstraZeneca takeover fight"
            data-share-img="http://s1.reutersmedia.net/resources/r/?m=02&d=20140526&t=2&i=900106729&w=1200&fh=&fw=&ll=&pl=&sq=&r=CBREA460M4L00"
            data-share="twitter,facebook,linkedin,mailArticle"
            data-share-id="USBREA3R0H520140526">
        </div></div>
</div></div>
    </nav>
    <div class="nav-white-space"></div>
    <div class="edition-header">
        <div class="container">
            <div class="selection-header"></div>
            <ul class="edition-list">
                <li>
                    <div class="item"><a href="http://af.reuters.com">Africa</a></div>
                    <div class="item"><a href="http://lta.reuters.com">América Latina</a></div>
                </li>
                <li>
                    <div class="item"><a href="http://ara.reuters.com">عربي</a></div>
                    <div class="item"><a href="http://ar.reuters.com">Argentina</a></div>
                </li>
                <li>
                    <div class="item"><a href="http://br.reuters.com">Brasil</a></div>
                    <div class="item"><a href="http://ca.reuters.com">Canada</a></div>
                </li>   
                <li>
                    <div class="item"><a href="http://cn.reuters.com" class="">中国</a></div>
                    <div class="item"><a href="http://de.reuters.com" class="">Deutschland</a></div>
                </li>
                <li>
                    <div class="item"><a href="http://es.reuters.com">España</a></div>
                    <div class="item"><a href="http://fr.reuters.com">France</a></div>
                </li>
                <li>
                    <div class="item"><a href="http://in.reuters.com" class="">India</a></div>
                    <div class="item"><a href="http://it.reuters.com">Italia</a></div>
                </li>
                <li>
                    <div class="item"><a href="http://jp.reuters.com" class="">日本</a></div>
                    <div class="item"><a href="http://mx.reuters.com">México</a></div>
                </li>
                <li>
                    <div class="item"><a href="http://ru.reuters.com">РОССИЯ</a></div>
                    <div class="item"><a href="http://uk.reuters.com" class="">United Kingdom</a></div>
                </li> 
                <li><div class="item"><a href="http://www.reuters.com" class="active">United States</a></div></li>
            </ul>
        </div>
    </div>
    
    <div id="content">
            <div id="overlayForSearch"></div><section>
	<div class="group" id="">
		<script type="text/javascript">
Reuters.namespace("info");
Reuters.info.articleId = 'USBREA3R0H520140526';
Reuters.info.articlePartnerURI = '';
Reuters.info.channel = 'innovationNews';
Reuters.info.articleUrl = '/article/us-astrazeneca-pfizer-idUSBREA3R0H520140526';
</script>

<!-- overrideType can be "video" -->

</div>
	</section><section class="main-content">
	<div class="group wrap" id="articleContent">
		<div id="div_gpt_lb" class="ad-leaderboard"><div class="ad" id="leaderboard">

		<script type="text/javascript">
var dz_final = TR3.extractDartZone();
// leaderboard
if( 'leaderboard' == 'leaderboard'){
    //US HOME FASTLANE
    if((TR3.extractDartZone().indexOf("us.reuters") > -1)){
        if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined')
        {displayAd_sync_fastlane(dz_final,  "articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel + ";" + adParams2 + "" );}
        else{ displayAd_sync_fastlane( dz_final, "articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
    }
    else{ if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined')
        { displayAd_sync(dz_final,  "articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel + ";" + adParams2 + "" ); }
        else{ displayAd_sync( dz_final, "articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
    }
}
else if('leaderboard' == 'mpu'){ googletag.cmd.push(function() { googletag.display('div_gpt_mpu'); }); }
else if('leaderboard' == 'mpulow'){ googletag.cmd.push(function() { googletag.display('div_gpt_mpulow'); }); }
else if('leaderboard' == 'leaderboardcenter'){
    if((TR3.extractDartZone().indexOf("us.reuters/home") > -1)){ googletag.cmd.push(function() { googletag.display('div_gpt_lb_center'); }); }
    else{ displayAd("div_gpt_lb", dz_final, [[728, 90],[970,250],[970,90],[970,66],[1,1]], "type=leaderboard;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
}
else if('leaderboard' == 'leaderboardlow'){
        if((TR3.extractDartZone().indexOf("us.reuters/home") > -1)){ googletag.cmd.push(function() { googletag.display('div_gpt_lb_low'); }); }
        else{ displayAd("div_gpt_lb", dz_final, [[728, 90],[970,250],[970,90],[970,66],[1,1]], "type=leaderboard;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
}
else{
    if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined'){
        displayAd("div_gpt_lb", dz_final, [[728, 90],[970,250],[970,90],[970,66],[1,1]], "type=leaderboard;articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel+ ";" + adParams2 + "" );
    } else{ displayAd("div_gpt_lb", dz_final, [[728, 90],[970,250],[970,90],[970,66],[1,1]], "type=leaderboard;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }	
}
</script>
        
        </div>

		</div><div class="linebreak"></div>
	

</div>
	</section><section>
	<div class="group wrap" id="rcs-articleHeader">
		<div class="column1 col col-10">
		<div class="article-header">
    <div class="article-info">
            <span class="article-section">
                <a href="/news/archive/innovationNews">Deals</a></span>
            <span class="divider">|</span>
            <span class="timestamp">Mon May 26, 2014 11:55am EDT</span>
        </div>
        
        <h1 class="article-headline">Pfizer walks away from $118 billion AstraZeneca takeover fight</h1>
            </div></div>

	<div class="column2 col col-4">
		</div>

</div>
	</section><section>
	<div class="group wrap" id="rcs-articleContent">
		<div class="column1 col col-10">
		<div class="related-photo landscape" id="articleImage">
                	           	<div class="related-photo-container">
                	           		<img
                                
                                        src="http://s1.reutersmedia.net/resources/r/?m=02&d=20140526&t=2&i=900106729&w=780&fh=&fw=&ll=&pl=&sq=&r=CBREA460M4L00"
                                
                                border="0" alt="The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly"
                                 />
		</div>
                			<div class="module-meta group">
        						<div class="module-caption">
                                	The Pfizer logo is seen at their world headquarters in New York April 28, 2014. <span class="module-credit">
                                	
                                		REUTERS/Andrew Kelly</span>
                                </div>
                            </div></div>
                	<div class="core-share  "
    data-share-short-url="http://reut.rs/1jmPMjr"
    data-share-url="http://www.reuters.com/article/us-astrazeneca-pfizer-idUSBREA3R0H520140526"
    data-share-title="Pfizer walks away from $118 billion AstraZeneca takeover fight"
    data-share-desc="LONDON/NEW YORK (Reuters) - Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker.
The decision ends a"
    data-share-img="http://s1.reutersmedia.net/resources/r/?m=02&d=20140526&t=2&i=900106729&w=1200&fh=&fw=&ll=&pl=&sq=&r=CBREA460M4L00"
    data-share="twitter,facebook,linkedin,mailArticle"
    data-share-id="USBREA3R0H520140526">
</div><span id="article-text">
<span id="midArticle_start"></span>

<div id="article-byline">
        <span class="author">By <a href="/journalists/ben-hirschler">Ben Hirschler</a> and <a href="/journalists/bill-berkrot">Bill Berkrot</a></span>
            <span class="location"><span class="divider">|</span> LONDON/NEW YORK</span> 
		</div>
<span id="midArticle_0"></span><span class="article-prime"><p><span class="articleLocation">LONDON/NEW YORK</span> Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker.</p></span><span id="midArticle_1"></span><p>The decision ends a month-long public fight between two of the world's biggest pharmaceutical companies that sparked political concerns on both sides of Atlantic over jobs and corporate tax maneuvers.</p><span id="midArticle_2"></span><p>British rules now require an enforced cooling-off period. AstraZeneca could reach out to Pfizer after three months and Pfizer could take another run at its smaller British rival in six months time, whether it is invited back or not.</p><span id="midArticle_3"></span><p>Pfizer's move came two hours before a 5.00 pm (1200 ET) deadline to make a firm offer or walk away, under UK takeover rules. Its decision to quit the stage, at least for now, had been widely expected after AstraZeneca refused its final offer of 55 pounds a share.</p><span id="midArticle_4"></span><p>"Following the AstraZeneca board's rejection of the proposal, Pfizer announces that it does not intend to make an offer for AstraZeneca," Pfizer said in a short news release.</p><span id="midArticle_5"></span><p>The biggest U.S. drugmaker promised it would not go hostile by taking its offer directly to AstraZeneca shareholders, leaving the fate of what would have been the world's largest ever drugs merger in the hands of its target, whose board would have had to make a complete U-turn to get a deal done.</p><span id="midArticle_6"></span><p>"We continue to believe that our final proposal was compelling and represented full value for AstraZeneca based on the information that was available to us," said Ian Read, Pfizer's chairman and chief executive.</p><span id="midArticle_7"></span>
            
            <span class="article-divide first-article-divide"></span><p>Pfizer's final offer was at a price that many analysts and investors had previously suggested would bring AstraZeneca to the table for serious negotiations.</p><span id="midArticle_8"></span><p>But in rejecting an earlier offer of 53.50 pounds as undervaluing the company, the British group indicated it needed a bid more than 10 percent higher, or at least 58.85 pounds per share, for its board to consider a recommendation.</p><span id="midArticle_9"></span><p>Pfizer had urged AstraZeneca shareholders to agitate for engagement and several expressed disappointment at its intransigence, although others - encouraged by AstraZeneca's promising drug pipeline - backed the firm's standalone strategy.</p><span id="midArticle_10"></span><p>AstraZeneca Chairman Leif Johansson welcomed Pfizer's decision to back down, which he said would allow the British company to focus on its growth potential as an independent company.</p><span id="midArticle_11"></span>
            
            <span class="article-divide second-article-divide"></span><p>What happens next will depend upon whether AstraZeneca's share price deteriorates in the coming weeks and how hard its shareholders push for it to revisit a deal with Pfizer.</p><span id="midArticle_12"></span><p>BlackRock, AstraZeneca's biggest shareholder, backed the board's rejection of Pfizer's 55 pounds a share offer, but urged it to talk again in the future.</p><span id="midArticle_13"></span><span class="article-subtitle"><p>POLITICAL OPPOSITION</p>
</span><span id="midArticle_14"></span><p>The proposed transaction ran into fierce opposition from politicians in Britain, Sweden - where AstraZeneca has half it roots - and the United States over the likelihood that the marriage would lead to thousands of job cuts.</p><span id="midArticle_15"></span><p>Ultimately, it was price and the lack of room for eleventh-hour maneuvering by Pfizer that killed the deal.</p><span id="midArticle_0"></span><p>Pfizer had several reasons for taking aim at AstraZeneca for what would have been its fourth mega-merger in 14 years.</p><span id="midArticle_1"></span><p>Highest on the list appeared to be Pfizer's desire to take part in a recent trend of so-called tax inversions, under which it could reincorporate in Britain and pay significantly lower corporate tax. Pfizer would also be able to use tens of billions of dollars it has parked overseas, avoiding high U.S. taxes for repatriating the huge cash pile.</p><span id="midArticle_2"></span><p>Pfizer also had its eye on a promising portfolio of drugs in AstraZeneca's developmental pipeline, especially several potentially lucrative cancer medicines.</p><span id="midArticle_3"></span><p>It was this pipeline that AstraZeneca management used to make its case for Pfizer significantly undervaluing the company.</p><span id="midArticle_4"></span><p>Chief Executive Pascal Soriot went as far as making a 10-year forecast for a 75 percent rise in sales by 2023.</p><span id="midArticle_5"></span><p>"As we said from the start, the pursuit of this transaction was a potential enhancement to our existing strategy," Pfizer's Read said. "We will continue our focus on the execution of our plans, bringing forth new treatments to meet patients' needs and remaining responsible stewards of our shareholders' capital."</p><span id="midArticle_6"></span><p>The merger would have restored Pfizer as the world's largest drugmaker by sales, a position it relinquished to Swiss-based Novartis when billions of dollars in annual revenue evaporated after its top-selling cholesterol fighter Lipitor began facing generic competition in 2011.</p><span id="midArticle_7"></span><p>(Editing by David Evans and Mark Potter)</p><span id="midArticle_8"></span></span>

<script type="text/javascript">
	
	var $relatedItems     = $('<li><a href="/article/us-astrazeneca-pfizer-climbdown-idUSBREA4P0CC20140526?mod=related&channelName=innovationNews">AstraZeneca welcomes Pfizer climbdown in takeover fight</a></li>'),
	    $relatedItems     = $relatedItems.slice(0,10),
	    relatedBlockLimit = Number('6'),
	    relatedItemsTotal = $relatedItems.length,
	    $paragraphTags    = $('#article-text p'),
	    contentParagraphs = 0,
	    minParagraphs     = Number("8");

	for (i=0; i < $paragraphTags.length; i++) {
		if ($paragraphTags[i].innerText.trim().length > 0) {
			contentParagraphs = contentParagraphs + 1;
		}
	}

	if (contentParagraphs > minParagraphs) {
		setTimeout(function(){
			if (relatedItemsTotal > relatedBlockLimit) {
				$('.first-article-divide').append('<div class="related-content group-one"><h3 class="related-content-title">Related Coverage</h3><ul></ul></div>');
				$('.second-article-divide').append($('.slider.slider-module'));
				$('.third-article-divide').append('<div class="related-content group-two"><h3 class="related-content-title">Related Coverage</h3><ul></ul></div>');
				var median                  = (relatedItemsTotal / 2);
				var $relatedContentGroupOne = $('.related-content.group-one ul');
				var $relatedContentGroupTwo = $('.related-content.group-two ul');

				$.each($relatedItems, function(k,v) {
					if (k + 1 <= median) {
						$relatedContentGroupOne.append($relatedItems[k]);
					} else {
						$relatedContentGroupTwo.append($relatedItems[k]);
					}
				});	
			} else {
				$('.third-article-divide').append($('<div class="related-content group-one"><h3 class="related-content-title">Related Coverage</h3><ul></ul></div>'));
				$('.related-content ul').append($relatedItems);
			}
		},500);	
	}
</script>

<div class="linebreak"></div>
	</div>

	<div class="column2 col col-4">
		<div class="module mod-sticky-article"><div class="section article-sticky">
<div class="sectionContent">
<div id="ad-div-mpu"><div id="div_gpt_mpu"><div class="ad" id="mpu">

		<script type="text/javascript">
var dz_final = TR3.extractDartZone();
// leaderboard
if( 'mpu' == 'leaderboard'){
    //US HOME FASTLANE
    if((TR3.extractDartZone().indexOf("us.reuters") > -1)){
        if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined')
        {displayAd_sync_fastlane(dz_final,  "articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel + ";" + adParams2 + "" );}
        else{ displayAd_sync_fastlane( dz_final, "articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
    }
    else{ if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined')
        { displayAd_sync(dz_final,  "articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel + ";" + adParams2 + "" ); }
        else{ displayAd_sync( dz_final, "articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
    }
}
else if('mpu' == 'mpu'){ googletag.cmd.push(function() { googletag.display('div_gpt_mpu'); }); }
else if('mpu' == 'mpulow'){ googletag.cmd.push(function() { googletag.display('div_gpt_mpulow'); }); }
else if('mpu' == 'leaderboardcenter'){
    if((TR3.extractDartZone().indexOf("us.reuters/home") > -1)){ googletag.cmd.push(function() { googletag.display('div_gpt_lb_center'); }); }
    else{ displayAd("div_gpt_mpu", dz_final, [[300, 250],[300,600],[300,1050]], "type=mpu;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
}
else if('mpu' == 'leaderboardlow'){
        if((TR3.extractDartZone().indexOf("us.reuters/home") > -1)){ googletag.cmd.push(function() { googletag.display('div_gpt_lb_low'); }); }
        else{ displayAd("div_gpt_mpu", dz_final, [[300, 250],[300,600],[300,1050]], "type=mpu;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
}
else{
    if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined'){
        displayAd("div_gpt_mpu", dz_final, [[300, 250],[300,600],[300,1050]], "type=mpu;articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel+ ";" + adParams2 + "" );
    } else{ displayAd("div_gpt_mpu", dz_final, [[300, 250],[300,600],[300,1050]], "type=mpu;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }	
}
</script>
        
        </div>

		</div><div class="linebreak"></div>
	

</div><div class="linebreak"></div>
	<div class="header-no-margin"><header class="module-header">
                        <h4 class="module-heading">
                                Trending <span class="title-last">Stories</span>
                                </h4>
                        </header>
                <div id="mostPopularRead"><div id="most-popular"><div class="moduleBody"><ul></ul></div><div id="most-popular-remark"></div></div></div><script type="text/javascript">
        var video_btn_url = '<img src="http://s3.reutersmedia.net/resources_v2/images/btn_rel_video.gif" border="0" height="11px" width="43px" alt="Video" />';
        var _raw_json_note = "not in use for this version";
	var max_json_num = 5;
	var filter_str = "/news/pictures";
	var filter_arr = [];
        filter_arr = filter_str.split(",");
 
	var parselyObjects= [{"data":[{"title":"Commentary: Evidence points to another Snowden at the NSA","_hits":"527","source":"charbeat","video_link":"","url":"http:\/\/www.reuters.com\/article\/us-intelligence-nsa-commentary-idUSKCN10X01P"},{"title":"Hundreds of Americans wash up illegally in Canada after river party","_hits":"367","source":"charbeat","video_link":"","url":"http:\/\/www.reuters.com\/article\/us-canada-usa-party-idUSKCN10X216"},{"title":"Over 1,900 killed in 'chilling' Philippines war on drugs","_hits":"262","source":"charbeat","video_link":"","url":"http:\/\/www.reuters.com\/article\/us-drug-police-idUSKCN10Y06P"},{"title":"Germany to tell people to stockpile food and water in case of attacks:  FAS","_hits":"211","source":"charbeat","video_link":"","url":"http:\/\/www.reuters.com\/article\/us-germany-security-stockpiling-idUSKCN10W0MJ"},{"title":"As Kerry lands in Nigeria, air force says top Boko Haram fighters killed","_hits":"207","source":"charbeat","video_link":"","url":"http:\/\/www.reuters.com\/article\/us-nigeria-security-bokoharam-idUSKCN10Y0JP"}]}];
	
		if (typeof Reuters.parsely.parseParsely == 'function') { Reuters.parsely.parseParsely(parselyObjects); } 
	</script>




</div></div></div>


</div><section class="mod-editors-pick module epnc">
			<header class="module-header">
				<h4 class="module-heading">
				Editor's <span class="title-last">Pick</span>
				</h4>
			</header>
        	<section class="module-content">
                <article>
                    <a href="http://live.reuters.com/Event/Election_2016"><div class="story-photo lazy-photo">
                        <img border="0" alt="" src="" org-src="http://static.reuters.com/resources/media/global/assets/images/20160817/20160817_4194156320160817120616.jpg"></a>
                    </div>
                    <div class="story-content">
                        <h2 class="story-title"><a href="http://live.reuters.com/Event/Election_2016">LIVE: Election 2016</a></h2>
                    </div>
                </article>
        	</section>
            
            </section>
        	<script>
			 	$(document).ready(function () {
					if(window.location.href.indexOf("http://live.reuters.com/Event/Election_2016") > -1) {
					   $('.epnc').hide();
					}
				});
			</script>
        	
        
		<script>
			 	$('.epnc').show();
				$(document).ready(function () {
					if(window.location.href.indexOf("http://blogs.reuters.com/breakingviews/2016/08/17/two-150-bln-plus-tech-giants-face-divergent-futures/") > -1) {
					   $('.epnc').hide();
					}
				});
				
			</script>
		

<div class="module"><div id="div_gpt_mpulow"><div class="ad" id="mpulow">

		<script type="text/javascript">
var dz_final = TR3.extractDartZone();
// leaderboard
if( 'mpulow' == 'leaderboard'){
    //US HOME FASTLANE
    if((TR3.extractDartZone().indexOf("us.reuters") > -1)){
        if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined')
        {displayAd_sync_fastlane(dz_final,  "articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel + ";" + adParams2 + "" );}
        else{ displayAd_sync_fastlane( dz_final, "articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
    }
    else{ if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined')
        { displayAd_sync(dz_final,  "articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel + ";" + adParams2 + "" ); }
        else{ displayAd_sync( dz_final, "articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
    }
}
else if('mpulow' == 'mpu'){ googletag.cmd.push(function() { googletag.display('div_gpt_mpu'); }); }
else if('mpulow' == 'mpulow'){ googletag.cmd.push(function() { googletag.display('div_gpt_mpulow'); }); }
else if('mpulow' == 'leaderboardcenter'){
    if((TR3.extractDartZone().indexOf("us.reuters/home") > -1)){ googletag.cmd.push(function() { googletag.display('div_gpt_lb_center'); }); }
    else{ displayAd("div_gpt_mpulow", dz_final, [[300, 250],[300,600],[1,1]], "type=mpulow;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
}
else if('mpulow' == 'leaderboardlow'){
        if((TR3.extractDartZone().indexOf("us.reuters/home") > -1)){ googletag.cmd.push(function() { googletag.display('div_gpt_lb_low'); }); }
        else{ displayAd("div_gpt_mpulow", dz_final, [[300, 250],[300,600],[1,1]], "type=mpulow;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
}
else{
    if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined'){
        displayAd("div_gpt_mpulow", dz_final, [[300, 250],[300,600],[1,1]], "type=mpulow;articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel+ ";" + adParams2 + "" );
    } else{ displayAd("div_gpt_mpulow", dz_final, [[300, 250],[300,600],[1,1]], "type=mpulow;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }	
}
</script>
        
        </div>

		</div><div class="linebreak"></div>
	

</div><div class="module"><header class="module-header">
                        <h4 class="module-heading">
                                Sponsored <span class="title-last">Topics</span>
                                </h4>
                        </header>
                <div class="linebreak"></div>
	<div id="div_gpt_article_rr2"><div class="ad" id="BizDev_Article_RR2">

		<script type="text/javascript">
var dz_final = TR3.extractDartZone();
// leaderboard
if( 'BizDev_Article_RR2' == 'leaderboard'){
    //US HOME FASTLANE
    if((TR3.extractDartZone().indexOf("us.reuters") > -1)){
        if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined')
        {displayAd_sync_fastlane(dz_final,  "articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel + ";" + adParams2 + "" );}
        else{ displayAd_sync_fastlane( dz_final, "articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
    }
    else{ if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined')
        { displayAd_sync(dz_final,  "articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel + ";" + adParams2 + "" ); }
        else{ displayAd_sync( dz_final, "articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
    }
}
else if('BizDev_Article_RR2' == 'mpu'){ googletag.cmd.push(function() { googletag.display('div_gpt_mpu'); }); }
else if('BizDev_Article_RR2' == 'mpulow'){ googletag.cmd.push(function() { googletag.display('div_gpt_mpulow'); }); }
else if('BizDev_Article_RR2' == 'leaderboardcenter'){
    if((TR3.extractDartZone().indexOf("us.reuters/home") > -1)){ googletag.cmd.push(function() { googletag.display('div_gpt_lb_center'); }); }
    else{ displayAd("div_gpt_article_rr2", dz_final, [[300,250],[1,1]], "type=BizDev_Article_RR2;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
}
else if('BizDev_Article_RR2' == 'leaderboardlow'){
        if((TR3.extractDartZone().indexOf("us.reuters/home") > -1)){ googletag.cmd.push(function() { googletag.display('div_gpt_lb_low'); }); }
        else{ displayAd("div_gpt_article_rr2", dz_final, [[300,250],[1,1]], "type=BizDev_Article_RR2;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }
}
else{
    if(typeof(Reuters)!='undefined' && typeof(Reuters.info)!='undefined' && typeof(Reuters.info.channel)!='undefined'){
        displayAd("div_gpt_article_rr2", dz_final, [[300,250],[1,1]], "type=BizDev_Article_RR2;articleID=USBREA3R0H520140526;storychannel=" + Reuters.info.channel+ ";" + adParams2 + "" );
    } else{ displayAd("div_gpt_article_rr2", dz_final, [[300,250],[1,1]], "type=BizDev_Article_RR2;articleID=USBREA3R0H520140526;" + adParams2 + "" ); }	
}
</script>
        
        </div>

		</div>

</div></div>

</div>
	</section><section>
	<div class="group wrap" id="rcs-articleAd1">
		<div class="column1 col col-10">
		<section  class="module  ">
		
		<section class="module-content">
		<header class="module-header">
				<h4 class="module-heading">Next In <span class='title-last'> Deals</span> </h4>
			</header><div class="next-article-container">    
    	<div class="next-articles">
    
	<div class="story">
		<div class="story-content">
			<a href="/article/us-dalianwanda-chairman-idUSKCN10Y13K"  ><div class="story-photo">
					<img
                                
					src="http://s4.reutersmedia.net/resources_v2/images/r-generic-hdr.png"
					org-src="http://s4.reutersmedia.net/resources/r/?m=02&d=20160823&t=2&i=1150727625&w=140&fh=&fw=&ll=&pl=&sq=&r=LYNXNPEC7M0IR"
                                
                                border="0" alt=""
                                 />
		</div>
            
	            <h3  class="story-title">Exclusive: China's richest man set to seal two billion-dollar U.S. film deals</h3></a>
	<p>BEIJING Real estate and entertainment conglomerate Dalian Wanda Group Co expects to seal two billion-dollar film-related deals in the United States this year, chairman Wang Jianlin said on Tuesday, as China's richest man steps up his push into Hollywood.</p>
            </div>
    </div>

	<div class="story">
		<div class="story-content">
			<a href="/article/us-sabmiller-m-a-a-b-i-idUSKCN10Y0Y4"  ><div class="story-photo">
					<img
                                
					src="http://s4.reutersmedia.net/resources_v2/images/r-generic-hdr.png"
					org-src="http://s4.reutersmedia.net/resources/r/?m=02&d=20160823&t=2&i=1150716434&w=140&fh=&fw=&ll=&pl=&sq=&r=LYNXNPEC7M0F8"
                                
                                border="0" alt=""
                                 />
		</div>
            
	            <h3  class="story-title">UK court says SABMiller shareholders can be split into two classes</h3></a>
	<p>LONDON SABMiller  shareholders can be treated as two separate groups when they vote on the brewer's 79 billion pound ($103 billion) takeover by Anheuser Busch InBev , a court in London ruled on Tuesday, granting a request from SAB aimed at making the vote as fair as possible.</p>
            </div>
    </div>

	<div class="story">
		<div class="story-content">
			<a href="/article/us-anbanginsurance-ipo-idUSKCN10Y0ZR"  ><div class="story-photo">
					<img
                                
					src="http://s4.reutersmedia.net/resources_v2/images/r-generic-hdr.png"
					org-src="http://s4.reutersmedia.net/resources/r/?m=02&d=20160823&t=2&i=1150718772&w=140&fh=&fw=&ll=&pl=&sq=&r=LYNXNPEC7M0FY"
                                
                                border="0" alt=""
                                 />
		</div>
            
	            <h3  class="story-title">Waldorf Astoria owner Anbang plans Hong Kong IPO of life insurance unit: sources</h3></a>
	<p>HONG KONG Anbang Insurance Group Co, which owns New York's Waldorf Astoria hotel, plans to list its life insurance business in Hong Kong and has invited investment banks to pitch for advisory mandates in the coming weeks, sources familiar with the matter said.</p>
            </div>
    </div>

	</div></div>

	</section>
		</section>

</div>

	<div class="column2 col col-4">
		<div class="module header-no-margin"><section class="mod-recirc">
<header class="module-header">
  <h4 class="module-heading">
MORE FROM <span class="title-last">REUTERS</span>
  </h4>
</header>
<section class="module-content">
<div id="taboola-recirc"></div>
<script type="text/javascript">
  window._taboola = window._taboola || [];
  _taboola.push({
    mode: 'organic-thumbnails-a',
    container: 'taboola-recirc',
    placement: 'Below Article Thumbnails - Organic',
    target_type: 'mix'
  });
</script>
</section>
</section></div></div>

</div>
	</section><section>
	<div class="group wrap" id="rcs-articleAd2">
		<div class="column1 col col-10">
		<header class="module-header">
    <h4 class="module-heading">From Around the <span class="title-last">Web</span> <span style="color: #ccc; float: right; font-size: 12px; font-weight: normal; margin-top: 3px; text-transform: none;"><a href="http://popup.taboola.com/en/?template=colorbox&taboola_utm_source=cox-clarkhoward&taboola_utm_medium=bytaboola&taboola_utm_content=thumbnails-b:Below%20Article%20Thumbnails%20-%20SC" style="color: #ccc; background: none;" target="_blank">By Taboola</a></span></h4>
</header><div class="module"><div id="taboola-below-article-thumbnails"></div>
<script type="text/javascript">
window._taboola = window._taboola || [];
_taboola.push(
{ mode: 'thumbnails-3X2', container: 'taboola-below-article-thumbnails', placement: 'Below Article Thumbnails', target_type: 'mix' }

);
</script>
<script type="text/javascript">
window._taboola = window._taboola || [];
_taboola.push(
{flush: true}

);
</script></div>

</div>

	<div class="column2 col col-4">
		<header class="module-header">
    <h4 class="module-heading">Sponsored <span class="title-last">Content</span> <span style="color: #ccc; float: right; font-size: 12px; font-weight: normal; margin-top: 3px; text-transform: none;"><a href="http://www.dianomi.com/cms/register-interest/?utm_source=network&utm_medium=smartad_sponsor_link " target="_blank" style="color: #ccc;background: none;">By Dianomi</a></span></h4>
</header><div class="module"><iframe valign="middle" width="300" height="444" marginheight=0 marginwidth=0 frameborder=0 vspace=0 hspace=0 scrolling=NO src="//www.dianomi.com/smartads.epl?id=2624"></iframe></div>

<div class="shr-overlay"><div id="weChatBox" class="shr-box shr-qr"><div class="shr-qr-top group"><a href="javascript:void(0)" onclick="shrBoxHide('weChatBox')" class="shr-qr-close">X</a></div><div id="shr-qrcode" class="shr-qr-content"></div></div></div></div>

</div>
	</section><section>
	<div class="group" id="">
		<div class="linebreak"></div>
	</div>
	</section></div>
<footer>
<section class="footer">
	<div class="group wrap" id="">
		<div id="section-follow-buttons"><span class="footer-follow">Follow Reuters: </span>
<ul>
    <li id="foot-twitter"><a href="http://www.twitter.com/reuters" target="_blank"><span class="follow-button follow-twitter">Follow Us On Twitter</span></a></li>
    <li id="foot-facebook"><a href="http://www.facebook.com/Reuters" target="_blank"><span class="follow-button follow-facebook">Follow Us On Facebook</span></a></li>
    <li id="foot-rssfeed"><a href="http://www.reuters.com/tools/rss" target="_blank"><span class="follow-button follow-rss">Follow Us On RSS</span></a></li>
    <li id="foot-instagram"><a href=" https://instagram.com/reuters/" target="_blank"><span class="follow-button follow-instagram">Follow Us On Instagram</span></a></li>
    <li id="foot-youtube"><a href="https://www.youtube.com/user/ReutersVideo" target="_blank"><span class="follow-button follow-youtube">Follow Us On YouTube</span></a></li>
    <li id="foot-linkedin"><a href="https://www.linkedin.com/company/thomson-reuters_1400" target="_blank"><span class="follow-button follow-linkedin">Follow Us On LinkedIn</span></a></li>
</ul></div><div class="footer-more-links"><span class="footer-more">Subscribe: </span>
<a href="http://www.reuters.com/tools/rss">Feeds</a> | <a href="http://newslink.reuters.com/join/subscribe">Newsletters</a> | <a href="/tools/podcasts">Podcasts</a> | <a href="/tools/mobile">Apps</a> </div></div>
	</section><section class="footer-body">
	<div class="group wrap" id="">
		<div class="footer-services-link"><a href="http://agency.reuters.com" target="_blank">Reuters News Agency</a> | <a href="http://agency.reuters.com/en/platforms-delivery/reuters-brand-attribution-guidelines.html" target="_blank">Brand Attribution Guidelines</a> | <a href="http://thomsonreuters.com/site/delivery-options/" target="_blank">Delivery Options</a></div><div class="disclaimer"><div class="footer-summary">
<p>Reuters is the news and media division of <a href="http://thomsonreuters.com/" target="_blank">Thomson Reuters</a>. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:</p>
</div></div><div class="product-container">
  <a href="http://financial.thomsonreuters.com/en/products/tools-applications/trading-investment-tools/eikon-trading-software.html" target="_blank">
    <div class="product">
      <div class="prod-title">Eikon</div>
        <div class="prod-content">Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface 
        </div>
    </div>
  </a>
  <a href="http://financial.thomsonreuters.com/en/products/infrastructure/trading-infrastructure/elektron-enterprise-data-management.html" target="_blank">  
    <div class="product">
      <div class="prod-title">Elektron</div>
        <div class="prod-content">Everything you need to empower your workflow and enhance your enterprise data management 
      </div>
    </div>
  </a>
  <a href="https://risk.thomsonreuters.com/products/world-check" target="_blank">  
    <div class="product">
      <div class="prod-title">World-Check</div>
      <div class="prod-content">Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks 
      </div>
    </div>
  </a>  
  <a href="http://legalsolutions.thomsonreuters.com/law-products/westlaw-legal-research/" target="_blank">
    <div class="product">
      <div class="prod-title">Westlaw</div>
      <div class="prod-content">Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology   
      </div>
    </div>
  </a>
  <a href="https://tax.thomsonreuters.com/products/brands/onesource/" target="_blank">  
    <div class="product">
      <div class="prod-title">ONESOURCE</div>
      <div class="prod-content">The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
      </div>
    </div>
  </a>
  <a href="https://tax.thomsonreuters.com/products/brands/checkpoint/" target="_blank">  
    <div class="product prod-last">
      <div class="prod-title">CHECKPOINT</div>
      <div class="prod-content">The industry leader for online information for tax, accounting and finance professionals 
      </div>
    </div>
  </a>  
</div><div class="linebreak"></div>
	<div class="footer-policy-links"><p> All quotes delayed a minimum of 15 minutes. <a href="/info/disclaimer">See here for a complete list</a> of exchanges and delays.</p>
<div class="footer-policies"><ul>
    
<li class="h-links">
<div class="reuters-copyright"><script type="text/javascript">var year = new Date();document.write('<a href="http://thomsonreuters.com/copyright/">&copy;  ' + year.getFullYear() + ' Reuters. All Rights Reserved.</a>');</script></div>
</li>
<li class="h-links"><a href="http://reuters.zendesk.com/" target="_blank">Site Feedback</a></li>
<li class="h-links"><a href="https://reuters.zendesk.com/anonymous_requests/new" target="_blank">Corrections</a></li>
<li class="h-links"><a href="http://sales.reuters.com/">Advertise With Us</a></li>
<li class="h-links"><a href="/advertising-guidelines">Advertising Guidelines</a></li>
<li class="h-links"><a href="http://info.evidon.com/pub_info/285?v=1" id="_bapw-link" target="_blank"><img id="_bapw-icon" border="0" width="11" align="top" src="https://cdn.betrad.com/pub/icon1.png" /> AdChoices</a></li>
<li class="h-links"><a href="/terms-of-use">Terms of Use</a></li>
<li class="h-links h-links-last"><a href="/privacy-policy">Privacy Policy</a></li>

</ul></div></div></div>
	</section>

</footer>

<script src="http://s4.reutersmedia.net/resources_v2/js/core-header.js" type="text/javascript"></script>
<script src="http://s3.reutersmedia.net/resources_v2/js/core-login.js" type="text/javascript"></script>
<script src="http://s2.reutersmedia.net/resources_v2/js/core-tracking.js" type="text/javascript"></script>
<script src="http://s2.reutersmedia.net/resources_v2/js/core-share.js" type="text/javascript"></script>
    <script src="http://s2.reutersmedia.net/resources_v2/js/libraries/core-lib.js" type="text/javascript"></script>
	<script src="http://s4.reutersmedia.net/resources_v2/js/core-modules.js" type="text/javascript"></script>
<script src="http://s2.reutersmedia.net/resources_v2/js/core-article.js" type="text/javascript"></script>

<!-- Teads -->

<script type="text/javascript">

  
 
      if ((!TR3.data.doNotFireTags) && (!!TR3.data.contentType && TR3.data.contentType == "articles")) {

var description;
var metas = document.getElementsByTagName('meta');

 for (var x=0,y=metas.length; x<y; x++) {
      if (metas[x].name == "DCSext.ChannelList") {
description = metas[x];
}
      }

var pathname = window.location.pathname;
    var channel_string = description.content;    

    if (channel_string.indexOf('retirement-news') >= 0)
{TR3.log("channel list: "+ channel_string);}

    else if (channel_string.indexOf('mark-miller') >= 0)
{TR3.log("channel list: "+ channel_string);}
    else if((pathname.indexOf('USKBN0M61X720150310') > -1) || (pathname.indexOf('USL1N0W730320150306') > -1) || (pathname.indexOf('USKBN0LZ2HF20150303') > -1) || (pathname.indexOf('USKBN0LY2BN20150302') > -1) || (pathname.indexOf('USKBN0LT28H20150225') > -1) || (pathname.indexOf('USKBN0LT27Y20150225') > -1) ){
           TR3.log("48 hours in, no Teads");
      }
        
        else if( (pathname.indexOf('USKCN0YY08B') > -1) || (pathname.indexOf('USKBN0OQ1R120150610') > -1) || (pathname.indexOf('USKCN0XM1EZ') > -1) || (pathname.indexOf('USKCN0RT1JO20150929') > -1) || (pathname.indexOf('USKBN0OX1RH20150617') > -1) || (pathname.indexOf('USKCN0YV1AB ') > -1) || (pathname.indexOf('USKBN0LG2MY20150212') > -1) || (pathname.indexOf('USKBN0ML1IM20150325') > -1) || (pathname.indexOf('USKCN0WU10P') > -1) || (pathname.indexOf('USKCN0YS18Q') > -1) || (pathname.indexOf('USKCN0YV1AB') > -1) || (pathname.indexOf('SKCN0ZE1QI') > -1) || (pathname.indexOf('USKCN0Z01KO') > -1) || (pathname.indexOf('USKCN0Z12E6') > -1) || (pathname.indexOf('USKCN0Z71O5') > -1)|| (pathname.indexOf('USKCN0Z21LH') > -1)|| (pathname.indexOf('USKCN0ZL1NE') > -1)|| (pathname.indexOf('USKCN0ZN1IK') > -1)) {        
           TR3.log("Orlando, No Teads");
      }
          
    else if( (pathname.indexOf('USKCN0ZS1RN') > -1)  || (pathname.indexOf('USKCN0ZU1O7') > -1)  || (pathname.indexOf('USKCN0ZZ1TO') > -1) || (pathname.indexOf('USKCN1012DY') > -1) || (pathname.indexOf('USKCN1061U1') > -1) || (pathname.indexOf('USKCN1081RM') > -1)) {
        TR3.log("Life Lessons, No Teads");
    }   
       
        
         else if (channel_string.indexOf('politics') >-1)
{TR3.log("channel list: "+ channel_string);}
        

    else {

    TR3.data.dartZone = TR3.extractDartZone();
var pnum = 17802;

    if (TR3.data.dartZone.indexOf('/business/') > -1)  
pnum = 22088;
 
else if (TR3.data.dartZone.indexOf('/markets/') > -1) 
pnum = 22091;

    else if (TR3.data.dartZone.indexOf('/tech/') > -1) 
pnum = 22089;

    else if (TR3.data.dartZone.indexOf('/money/') > -1)  
pnum = 22090;

    else if (TR3.data.dartZone.indexOf('/politics/') > -1)  
pnum = 21072;

    else if (TR3.data.dartZone.indexOf('/life/') > -1)  
pnum = 21071;
      

    window._ttf = window._ttf || [];
    window._ttf.push({
    pid:pnum, 
    slot:'#articleText > p', 
    lang:'en', format:'inread', 
    capping : { 'time_interval' : 'day', 'frequency' : 4},
    components: {mute: {delay: 0},skip: {delay: 0}},
    mutable:false,
    skippable : true,
 passBack: function() {
var pnum;
var site_pathname = TR3.extractDartZone();
if (site_pathname.match(/business/g)) {
  pnum = 51749;
} else if (site_pathname.match(/markets/g)) {
  pnum = 51750;
} else if (site_pathname.match(/tech/g)) {
  pnum = 51751;
} else if (site_pathname.match(/money/g)) {
  pnum = 51752;
} else if (site_pathname.match(/politics/g)) {
  pnum = 51753;
} else if (site_pathname.match(/life/g)) {
  pnum = 51754;
} else if (site_pathname.match(/sectors/g)) {
  pnum = 51750;
} else if (site_pathname.match(/sports/g)) {
  pnum = 51754;
} else {
  pnum = 49570;  
}

window._ttf = window._ttf || [];
    window._ttf.push({
    pid:pnum, 
    slot:'#articleText > p',
    lang:'en', format:'inread', 
    capping : { 'time_interval' : 'day', 'frequency' : 2},
    components: {mute: {delay: 0},skip: {delay: 0}},
    mutable:false,
    skippable : true
});

(function (d) {
     var js, s = d.getElementsByTagName('script')[0];
     js = d.createElement('script');
     js.async = true;
     js.src = '//cdn.teads.tv/media/format.js';
        s.parentNode.insertBefore(js, s);
})(window.document);
}
});

TR3.writeScript('//cdn.teads.tv/media/format.js');
TR3.log("InRead new7 0820 w/ capping is inserted with "+ pnum);    
}}


    
</script><script language="javascript" type="text/javascript" src="http://www.reuters.com/reuters_gpt_bootstrap_footer.js"></script>

<script type="text/javascript">
	$(document).ready( function() {
		var sclTracking = new rcom_scrollTracker("Article");
		if( inAppleMobileDevice() ) {document.addEventListener("scroll", sclTracking, false);} else {$(window).scroll( sclTracking );}
	});
</script>

<section>
	<div class="group" id="">
		<script type='text/javascript'>
        var _sf_startpt = (new Date()).getTime();
        var _sf_async_config = _sf_async_config || {};
        
        _sf_async_config.sections = 'Deals'; 
        _sf_async_config.autoDetect = false;
        
        _sf_async_config.authors = 'Ben Hirschler'; 
        _sf_async_config.type = 'Article'; 

        (function(){
          function loadChartbeat() {
            window._sf_endpt=(new Date()).getTime();
            var e = document.createElement('script');
            e.setAttribute('language', 'javascript');
            e.setAttribute('type', 'text/javascript');
            e.setAttribute('src', '//static.chartbeat.com/js/chartbeat_video.js');
            document.body.appendChild(e);
          }
          var oldonload = window.onload;
          window.onload = (typeof window.onload != 'function') ?
             loadChartbeat : function() { oldonload(); loadChartbeat(); };
        })();
    </script>
</div>
	</section>

</body>
</html>
